Managed care allergy survey
This article was originally published in The Tan Sheet
Executive Summary
Forty-eight percent of managed care organizations "promote or have educational programs to utilize [Schering-Plough's] Claritin (OTC) over Clarinex (Rx)," according to survey conducted by The New England Consulting Group on "the draconian steps being taken to reduce pharmaceutical costs." Data compiled from responses of 41 major MCOs also indicates 78% of health plans have "promoted or educated...members on OTC allergy alternatives to Clarinex, [Aventis'] Allegra and [Pfizer's] Zyrtec"...